|
|
Post by cretin11 on Apr 4, 2023 12:58:17 GMT -5
Reading comprehension, gorman. I recommend trying it.
|
|
|
|
Post by awesomo on Apr 4, 2023 13:40:22 GMT -5
I call out B.S. claims, which on this board happens to be things like "V-Go will be profitable in one year". If this board was making similar claims to the negative and nobody was saying anything, I would call that out too. I would not exactly call what I said a bullshit claim. We paid 10M for VGo and it has done well so far. ”We continue to see V-Go net revenue tracking at the high end of our forecast range of $18 million to $22 million for the 12 months post-acquisition.” You don’t seem to understand the difference between net revenue and profitability. Revenue doesn’t include costs. I don’t care if you make $100M if you had to spend $120M to get it, that’s not profitable. |
|
|
|
Post by mango on Apr 4, 2023 13:50:54 GMT -5
I would not exactly call what I said a bullshit claim. We paid 10M for VGo and it has done well so far. ”We continue to see V-Go net revenue tracking at the high end of our forecast range of $18 million to $22 million for the 12 months post-acquisition.” You don’t seem to understand the difference between net revenue and profitability. Revenue doesn’t include costs. I don’t care if you make $100M if you had to spend $120M to get it, that’s not profitable. You assume and make implications too much. I’ve very aware of the differences. Have a look at the operating expenses for VGo YE 2022 and report back. Keep in mind that we also acquired employees and additional product with the 10M purchase so VGo by itself was less than $10M. |
|
|
|
Post by bones1026 on Apr 4, 2023 13:59:29 GMT -5
Reading comprehension, gorman. I recommend trying it. Honesty, Cretin, I recommend trying it. |
|
|
|
Post by awesomo on Apr 4, 2023 14:20:28 GMT -5
You don’t seem to understand the difference between net revenue and profitability. Revenue doesn’t include costs. I don’t care if you make $100M if you had to spend $120M to get it, that’s not profitable. You assume and make implications too much. I’ve very aware of the differences. Have a look at the operating expenses for VGo YE 2022 and report back. Keep in mind that we also acquired employees and additional product with the 10M purchase so VGo by itself was less than $10M. Those employees cost money, it's not like they just bought a bunch of robots. V-Go was acquired in Q2... V-Go's gross margin in 2022 was 43%, so on $12.9M revenue they are +$5.5M taking into account COGS. SG&A expenses increased in Q2 to Q4 2022 by $11M YoY. So there's already a discrepancy of -$5.5M, a far cry from "profitable" which would assume V-Go will attribute over $10M in PROFIT to the company by Q2 2023. Feel free to show the operating expenses you talked about that show V-Go has been such a success... |
|
|
|
Post by hellodolly on Apr 4, 2023 14:31:23 GMT -5
I looked back at the last seven (7) 10Ks filed with the SEC and discovered this, for what it's worth on the front page of every filing, in shares by year:
2017 - 95,776,246
2018 - 120,467,137
2019 - 187,342,566
2020 - 212,295,318
2021 - 247,158,297
2022 - 251,798,303
2023 - 263,923,726
Average share price per year, tossing the outliers in the highs and the lows and used the open and closing price each year:
2017: $2.83
2018: $1.70
2019: $1.18
2020: $2.77
2021: $3.76
2022: $4.81
2023: Incomplete data
Draw your own conclusions with the data. Mike came in with a shit show, stopped the bleeding, reorganized and executed his plan. You can hate it or you can like it. He doesn't really care one way or the other what we feel and neither do the key pieces of the puzzle; UTHR, State Street, Vanguard, Black Rock, etc. My focus is on the SP and so far, I'm satisfied, considering we were one qtr away from shitting the bed.
|
|
|
|
Post by hellodolly on Apr 4, 2023 14:46:21 GMT -5
You assume and make implications too much. I’ve very aware of the differences. Have a look at the operating expenses for VGo YE 2022 and report back. Keep in mind that we also acquired employees and additional product with the 10M purchase so VGo by itself was less than $10M. Those employees cost money, it's not like they just bought a bunch of robots. V-Go was acquired in Q2... V-Go's gross margin in 2022 was 43%, so on $12.9M revenue they are +$5.5M taking into account COGS. SG&A expenses increased in Q2 to Q4 2022 by $11M YoY. So there's already a discrepancy of -$5.5M, a far cry from "profitable" which would assume V-Go will attribute over $10M in PROFIT to the company by Q2 2023. Feel free to show the operating expenses you talked about that show V-Go has been such a success... All attributed to just V-Go or to MNKD as a whole? I haven't looked yet. |
|
|
|
Post by lennymnkd on Apr 4, 2023 15:24:00 GMT -5
For the possibility of a hostile takeover to be possible Technosphere and afrezza would have to be as good as we have been saying on this board for years. Is it? Is Tyvaso DPI any good? Are these continuing reports and videos of afrezza by T1s being the best insulin they have taken true? Could afrezza be the best approach for treating T2s? Does MNKD have a TS based GLP1 solution siting on the shelf? Is afrezza's biggest problem not a medical problem but a marketing problem? Would someone like a Mark Cuban who thinks MNKDs issue is a marketing issue try and buy MNKD? He already has costpludrugs.com If CGMs really do have the potential of jump starting T2 sales of afrezza through the Medicare channel would someone not be interested? You just never know what the future will bring. Isn't it always best to be prepared than caught blind? When did Mark Cuban say MannKind’s issue was a marketing issue? Can you post the video or article to that please? First I am hearing Mark Cuban even knows about MannKind let alone him discussing Afrezza sales and marketing. Well I think it’s a marketing issue if that matters 🤪 |
|
|
|
Post by cretin11 on Apr 4, 2023 16:00:59 GMT -5
Reading comprehension, gorman. I recommend trying it. Honesty, Cretin, I recommend trying it. Agree, honesty is the only way I know. Calling out BS is another habit. Sorry if it offends you, but not planning to change now. |
|
|
|
Post by sayhey24 on Apr 4, 2023 16:02:38 GMT -5
When did Mark Cuban say MannKind’s issue was a marketing issue? Can you post the video or article to that please? First I am hearing Mark Cuban even knows about MannKind let alone him discussing Afrezza sales and marketing. Well I think it’s a marketing issue if that matters 🤪 Sorry Mango - I guess you were not included on the emails  Could Mark Cuban do a better job at marketing afrezza? Could he do worse??? IDK, Mark could very well run MNKD into the ground but then again maybe not or at least MNKD would become a household name and the pps would probably pop. What about that TS GLP1 sitting on the shelf??? Hey Mark - ever hear of Mounjaro and its potential for weight loss??? Probably not this time last year. Remember, Mark was running around last year talking about how costplusdrugs.com was going to bring $35 insulin to the market but when you tell him you can already go to Walmart and get insulin for $25 what do you think he thinks? Of course then Medicare does provide ALL insulin for $35 including afrezza. Whats that about 50% of the insulin market? Why is MNKD not having an in person annual meeting??? I still remember the guy trying to have the CCP buy MNKD. He was sitting a few rows in front of me. I am a bit sad as I planned to attend if it was in Danbury. TBH I think its a disgrace. |
|
|
|
Post by cretin11 on Apr 4, 2023 16:07:16 GMT -5
Still haven’t heard a good reason for no in person meeting.
Mark Cuban in charge of MNKD? Yes please! We would see some real changes, meaningful collaborations and partnerships, successful commercializations, etc.
|
|
|
|
Post by lennymnkd on Apr 4, 2023 16:21:32 GMT -5
I was also at meeting CCP .. was kind of out of the ordinary!
A few people thought he went upstairs to talk
After the meeting 😀
|
|
|
|
Post by mango on Apr 4, 2023 16:27:42 GMT -5
Still haven’t heard a good reason for no in person meeting. Mark Cuban in charge of MNKD? Yes please! We would see some real changes, meaningful collaborations and partnerships, successful commercializations, etc. It makes no logical sense for you to be “invested” in this stock considering you despise its leadership and BoDs, and pretty much anything that has to do with the company. The CEO isn’t going anywhere anytime soon. It must take a toll on your health to be so negative 24/7/365 about a stock, eh? Strange investment strategy, indeed. |
|
|
|
Post by peppy on Apr 4, 2023 16:29:50 GMT -5
I was also at meeting CCP .. was kind of out of the ordinary!A few people thought he went upstairs to talk After the meeting 😀 I remember. Many years ago now. You are talking about the person who said he was from China, wanting to buy a piece of Mannkind correct? |
|
|
|
Post by mango on Apr 4, 2023 16:37:11 GMT -5
I was also at meeting CCP .. was kind of out of the ordinary!A few people thought he went upstairs to talk After the meeting 😀 I remember. Many years ago now. You are talking about the person who said he was from China, wanting to buy a piece of Mannkind correct? I remember watching the shareholder video of that guy. Was such a funny moment, so random, ha ha. |
|
